A FIRST-IN-HUMAN TRIAL OF AN INTEGRIN BETA-6 TARGETED ANTIBODY-DRUG CONJUGATE (ADC), SGNB6A, IN PATIENTS WITH ADVANCED SOLID TUMORS: INTERIM RESULTS OF A PHASE 1 STUDY (SGNB6A-001)

被引：1

作者：

Hollebecque, Antoine ^{[1
]}

Lopez, Juanita ^{[2
]}

Piha-Paul, Sarina ^{[3
]}

Dowlati, Afshin ^{[4
]}

Patnaik, Amita ^{[5
]}

Galvao, Vladimir ^{[6
]}

Buckorny, Bruno ^{[7
]}

Sehgal, Kartik ^{[8
]}

Kingsley, Edwin ^{[9
]}

Sanborn, Rachel ^{[10
]}

Peters, Solange ^{[11
]}

Sun, Yan ^{[12
]}

Patilea-Vrana, Gabriela ^{[12
]}

Nazarenko, Natalya ^{[12
]}

Calvo, Emiliano ^{[13
]}

机构：

[1] Inst Gustave Roussy, Villejuif, France

[2] Royal Marsden Hosp Surrey, London, England

[3] Univ Texas Houston, Houston, TX USA

[4] Case Western Reserve Univ, Cleveland, OH USA

[5] START San Antonio, San Antonio, TX USA

[6] Vall dHebron Inst Oncol, Barcelona, Spain

[7] Beth Israel Deaconess Med Ctr, Boston, MA USA

[8] Dana Farber Canc Inst, Boston, MA USA

[9] Comprehens Canc Ctr Nevada, Las Vegas, NV USA

[10] Earle A Chiles Res Inst, Portland, OR USA

[11] CHU Vaudois, Lausanne, Switzerland

[12] Seagen Inc, Bothell, WA USA

[13] START Madrid CIOCC, Madrid, Spain

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷

关键词：

D O I：

10.1136/jitc-2022-SITC2022.0731

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

731

引用

页码：A763 / A763

页数：1

共 50 条

[31] A first-in-human phase I study of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors [J].

Ray-Coquard, I. L. ;

Liu, J. F. ;

O'Malley, D. ;

Oaknin, A. ;

Pothuri, B. ;

Lorusso, D. ;

Eskander, R. N. ;

Westin, S. ;

Lakhani, N. J. ;

McKean, W. B. ;

Koyama, T. ;

Kitano, S. ;

Lim, M. C. ;

Gomez-Roca, C. A. ;

Perez Fidalgo, J. A. ;

Curigliano, G. ;

Campone, M. ;

Sharkey, B. ;

Avsar, E. ;

Friedman, C. .

ANNALS OF ONCOLOGY, 2024, 35 :S593-S594

[32] First-in-human study of SGN-B7H4V, a B7-H4-directed vedotin ADC, in patients with advanced solid tumors: Preliminary results of a phase I study (SGNB7H4V-001) [J].

Perez, C. A. ;

Henry, J. T. ;

Lakhani, N. ;

Call, J. A. ;

Hamilton, E. P. ;

Colon-Otero, G. ;

Diamond, J. R. ;

O'Neil, B. ;

Kalyan, A. ;

Sonpavde, G. P. ;

Candilejo, I. Moreno ;

Awan, A. A. ;

Fontana, E. ;

Xu, P. ;

Zhang, F. ;

Nazarenko, N. ;

Patnaik, A. .

ANNALS OF ONCOLOGY, 2023, 34 :S464-+

[33] First-in-human phase I trial of the anti-CEACAM5 antibody-drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848) [J].

Gazzah, A. ;

Stjepanovic, N. ;

Ryu, M. H. ;

Tabernero, J. ;

Soria, J. C. ;

Bedard, P. ;

Kang, Y. K. ;

Bahleda, R. ;

Guillemin-Paveau, H. ;

Henry, C. ;

Hatteville, L. ;

Zilocchi, C. ;

Demers, B. ;

Hierro, C. .

EUROPEAN JOURNAL OF CANCER, 2016, 69 :S14-S15

[34] Initial results from a first-in-human study of the B7-H4-directed antibody-drug conjugate (ADC) AZD8205 (puxitatug samrotecan) in patients with advanced/metastatic solid tumors [J].

Meric-Bernstam, F. ;

Naito, Y. ;

Gaillard, S. ;

Shimoi, T. ;

Chung, V. ;

Davis, A. A. ;

Proia, T. ;

Ayyoub, A. ;

Kulkarni, M. ;

Upadhyay, S. ;

Miller, N. ;

Luheshi, N. ;

Varga, A. ;

Oh, D-Y. ;

Mileshkin, L. .

ANNALS OF ONCOLOGY, 2024, 35 :S485-S486

[35] First-in-human study of ABBV-400, a novel c-Met-targeting antibody-drug conjugate, in advanced solid tumors: Results in colorectal cancer [J].

Sharma, Manish ;

Strickler, John H. ;

Sommerhalder, David ;

Kuboki, Yasutoshi ;

Perets, Ruth ;

Cohen, Jonathan ;

Raimbourg, Judith ;

Nakajima, Takako Eguchi ;

Yamamoto, Noboru ;

Cruz-Correa, Marcia ;

O'Neil, Bert ;

Ghiringhelli, Francois ;

Raghav, Kanwal Pratap Singh ;

Li, Rui ;

Thiele, Gladys Morrison ;

Aristide, Martha Raluca Neagu ;

Freise, Kevin Jay ;

de Almeida, Carla Biesdorf ;

Vasilopoulos, Athanasios ;

Powderly, John D., II .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

[36] BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic solid tumor: Results from a first-in-human phase 1 study [J].

Zhang, Li ;

Ma, Yuxiang ;

Zhao, Yuanyuan ;

Fang, Wenfeng ;

Zhao, Hongyun ;

Huang, Yan ;

Yang, Yunpeng ;

Chen, Likun ;

Hou, Xue ;

Zou, Wen ;

Ding, Muran ;

Yu, Jing ;

Zhang, Suoyu ;

Wang, Junxian ;

Xiao, Sa ;

Wang, Hongwei ;

Zhu, Hai ;

Olivo, Martin Sebastian ;

Zhu, Yi .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

[37] First-in-Human Phase I Study of ABBV-085, an Antibody-Drug Conjugate Targeting LRRC15, in Sarcomas and Other Advanced Solid Tumors [J].

Demetri, George D. ;

Luke, Jason J. ;

Hollebecque, Antoine ;

Powderly, John D. ;

Spira, Alexander I. ;

Subbiah, Vivek ;

Naumovski, Louie ;

Chen, Chris ;

Fang, Hua ;

Lai, Dominic W. ;

Yue, Huibin ;

Polepally, Akshanth R. ;

Purcell, James W. ;

Robinson, Randy ;

Sharma, Padmanee ;

Allison, James P. ;

Tolcher, Anthony ;

Villalobos, Victor M. .

CLINICAL CANCER RESEARCH, 2021, 27 (13) :3556-3566

[38] First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors [J].

Strickler, John H. ;

Weekes, Colin D. ;

Nemunaitis, John ;

Ramanathan, Ramesh K. ;

Heist, Rebecca S. ;

Morgensztern, Daniel ;

Angevin, Eric ;

Bauer, Todd M. ;

Yue, Huibin ;

Motwani, Monica ;

Parikh, Apurvasena ;

Reilly, Edward B. ;

Afar, Daniel ;

Naumovski, Louie ;

Kelly, Karen .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (33) :3298-+

[39] A first-in-human phase I study of the anti-PD-1 antibody PDR001 in patients with advanced solid tumors [J].

Naing, Aung ;

Gelderblom, Hans ;

Gainor, Justin F. ;

Forde, Patrick M. ;

Butler, Marcus ;

Lin, Chia-Chi ;

Sharma, Sunil ;

de Olza, Maria Ochoa ;

Schellens, Jan H. M. ;

Soria, Jean-Charles ;

Taylor, Matthew H. ;

Silva, Antonio P. ;

Li, Zhonggai ;

Bilic, Sanela ;

Cameron, Scott ;

Infante, Jeffrey R. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

[40] First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid Tumors [J].

Shimizu, Toshio ;

Fujiwara, Yutaka ;

Yonemori, Kan ;

Koyama, Takafumi ;

Sato, Jun ;

Tamura, Kenji ;

Shimomura, Akihiko ;

Ikezawa, Hiroki ;

Nomoto, Maiko ;

Furuuchi, Keiji ;

Nakajima, Ryo ;

Miura, Takuma ;

Yamamoto, Noboru .

CLINICAL CANCER RESEARCH, 2021, 27 (14) :3905-3915

← 1 2 3 4 5 →